Vjhemonc Video Journal Of Hematology Hemonc

iStopMM: the psychological effects of MGUS screening and changes to clinical presentation of myeloma 5:11
iStopMM: the psychological effects of MGUS screening and changes to clinical presentation of myeloma VJHemOnc – Video Journal of Hematology & HemOnc 168 9 месяцев назад
Welcome to the Video Journal of Hematology & Hematological Oncology 🩸 3:08
Welcome to the Video Journal of Hematology & Hematological Oncology 🩸 VJHemOnc – Video Journal of Hematology & HemOnc 692 4 месяца назад
Defining high-risk myeloma: exciting updates and their implications 2:07
Defining high-risk myeloma: exciting updates and their implications VJHemOnc – Video Journal of Hematology & HemOnc 60 9 дней назад
The potential of adding anti-CD20 antibodies to acalabrutinib and venetoclax in CLL 1:21
The potential of adding anti-CD20 antibodies to acalabrutinib and venetoclax in CLL VJHemOnc – Video Journal of Hematology & HemOnc 87 7 дней назад
Exploring the biological mechanisms driving MBL progression to CLL 1:01
Exploring the biological mechanisms driving MBL progression to CLL VJHemOnc – Video Journal of Hematology & HemOnc 45 3 недели назад
The efficacy of CAR T-cell therapy in Richter’s transformation 1:16
The efficacy of CAR T-cell therapy in Richter’s transformation VJHemOnc – Video Journal of Hematology & HemOnc 93 3 недели назад
Haploidentical transplant in Argentina 0:42
Haploidentical transplant in Argentina VJHemOnc – Video Journal of Hematology & HemOnc 95 1 год назад
WM-NET: upcoming clinical trials to advance the treatment of WM 1:42
WM-NET: upcoming clinical trials to advance the treatment of WM VJHemOnc – Video Journal of Hematology & HemOnc 49 10 дней назад
Elranatamab for R/R myeloma: long-term updates from MagnetisMM-3 & real-world safety of this agent 6:07
Elranatamab for R/R myeloma: long-term updates from MagnetisMM-3 & real-world safety of this agent VJHemOnc – Video Journal of Hematology & HemOnc 525 4 месяца назад
Coagulation Cascade - Easy Way To Remember Intrinsic vs Extrinsic Pathways | PT or PTT? 6:36
Coagulation Cascade - Easy Way To Remember Intrinsic vs Extrinsic Pathways | PT or PTT? Rhesus Medicine 325,953 4 года назад
Will CAR-T be best when used in early relapse in myeloma? 2:16
Will CAR-T be best when used in early relapse in myeloma? VJHemOnc – Video Journal of Hematology & HemOnc 188 1 месяц назад
Hematology Lecture 1:46:07
Hematology Lecture Alex Sargsyan 70,122 7 лет назад
An update on the QuANTUM-First trial: quizartinib plus chemotherapy in FLT3-mutated AML 9:44
An update on the QuANTUM-First trial: quizartinib plus chemotherapy in FLT3-mutated AML VJHemOnc – Video Journal of Hematology & HemOnc 760 4 месяца назад
Updates on HBI0101, a CAR T-cell therapy, for R/R multiple myeloma 5:23
Updates on HBI0101, a CAR T-cell therapy, for R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 89 7 дней назад
Current barriers to early intervention in myelofibrosis 1:58
Current barriers to early intervention in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 132 1 месяц назад
New approaches to treating transplant-ineligible multiple myeloma: triplets and quadruplets 3:26
New approaches to treating transplant-ineligible multiple myeloma: triplets and quadruplets VJHemOnc – Video Journal of Hematology & HemOnc 297 2 месяца назад
Personalizing the timing of SCT in patients with myelofibrosis 2:13
Personalizing the timing of SCT in patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 130 1 месяц назад
HEMATOLOGY; PART 1 by Professor Fink.wmv 54:20
HEMATOLOGY; PART 1 by Professor Fink.wmv professorfink 209,523 12 лет назад
The role of asparaginase in the treatment of ALL 3:02
The role of asparaginase in the treatment of ALL VJHemOnc – Video Journal of Hematology & HemOnc 134 3 месяца назад
Analyzing the BM immune microenvironment in RAS/RAF-mutated myeloma treated with a MEK inhibitor 5:12
Analyzing the BM immune microenvironment in RAS/RAF-mutated myeloma treated with a MEK inhibitor VJHemOnc – Video Journal of Hematology & HemOnc 62 7 дней назад
Using MRD to guide treatment decisions in myeloma 1:15
Using MRD to guide treatment decisions in myeloma VJHemOnc – Video Journal of Hematology & HemOnc 159 6 месяцев назад
Examining biomarkers in WM cells to predict which patients will relapse 1:11
Examining biomarkers in WM cells to predict which patients will relapse VJHemOnc – Video Journal of Hematology & HemOnc 47 8 дней назад
Getting involved in real-world studies for CLL through ERIC 1:00
Getting involved in real-world studies for CLL through ERIC VJHemOnc – Video Journal of Hematology & HemOnc 19 10 дней назад
Early detection and interception across hematological cancers 0:44
Early detection and interception across hematological cancers VJHemOnc – Video Journal of Hematology & HemOnc 161 6 месяцев назад
The importance of MRD as a prognostic tool in multiple myeloma 1:36
The importance of MRD as a prognostic tool in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 143 1 год назад
Advice for physicians when managing bispecific antibody treatment for patients with myeloma 0:47
Advice for physicians when managing bispecific antibody treatment for patients with myeloma VJHemOnc – Video Journal of Hematology & HemOnc 138 3 месяца назад
Phase I trial of MCARH109, a GPRC5D-directed CAR T-cell, for patients with R/R multiple myeloma 3:00
Phase I trial of MCARH109, a GPRC5D-directed CAR T-cell, for patients with R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 85 2 недели назад
Results from the Phase III ECHO trial of acalabrutinib plus BR in MCL 2:49
Results from the Phase III ECHO trial of acalabrutinib plus BR in MCL VJHemOnc – Video Journal of Hematology & HemOnc 281 2 месяца назад
The potentially curative role of CAR-T therapy in myeloma 1:01
The potentially curative role of CAR-T therapy in myeloma VJHemOnc – Video Journal of Hematology & HemOnc 367 6 месяцев назад

Сейчас ищут